Research Article Vitamin D supplementation for children with mild to moderate asthma: an economic evaluation Jefferson Antonio Buendía MD, PhD, Diana Guerrero Patiño RN, MSc & Erika Fernanda Lindarte MSc Pages: 1-9 | DOI: 10.1080/02770903.2023.2178007 Dupilumab long-term efficacy in patients with non–OCS–dependent asthma with and without evidence of allergic asthma Lawrence D. Sher MD, Jonathan Corren MD, Ian D, Pavord MD, Nadia Daizadeh PhD, Arman Altincatal MS, Xavier Soler MD, PhD, Michel Djandji MD, Amr Radwan MB, BChir, FFPM, Juby A. Jacob-Nara MD, MPH, DHSc, Yamo Deniz MD & Paul J. Rowe MD, ATSF Pages: 1-10 | DOI: 10.1080/02770903.2023.2185895 This is the author accepted version which has not been proofed or edited Screening for asthma in preschool children with sickle cell disease. Kok Hoe Chan MD, James M. Stark MD, Ricardo A. Mosquera MD, Deborah L. Brown MD, Neethu Menon MD, Trinh T. Nguyen DO & Aravind Yadav MD Pages: 1-9 | DOI: 10.1080/02770903.2023.2187305 This is the author accepted version which has not been proofed or edited Changes in Caregiver Mental Health and Pediatric Asthma Control during COVID-19 Katherine D. Lohr M.S., Robin S. Everhart Ph.D., Rachel L. Holder M.S., Rachel Boutté Ph.D., Rosalie Corona Ph.D. & Suzanne E. Mazzeo Ph.D. Pages: 1-16 | DOI: 10.1080/02770903.2023.2185892 This is the author accepted version which has not been proofed or edited TURKISH VALIDITY AND RELIABILITY STUDY FOR THE PERCEIVED CONTROL OF ASTHMA QUESTIONNAIRE Ziya KOÇAK RN & Huri Seval GÖNDEREN ÇAKMAK RN Pages: 1-13 | DOI: 10.1080/02770903.2023.2185156 This is the author accepted version which has not been proofed or edited |
Recent Posts
- 17q21 Variants Disturb Mucosal Host Defense in Childhood Asthma
- TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
- New for Journal of Asthma online now on Taylor & Francis Online
- The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma
- Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-asthma Biologics